HomeCompareVCON vs MRK

VCON vs MRK: Dividend Comparison 2026

VCON yields 3.08% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $32.4K in total portfolio value
10 years
VCON
VCON
● Live price
3.08%
Share price
$65.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.4K
Annual income
$375.14
Full VCON calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — VCON vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVCONMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VCON + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VCON pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VCON
Annual income on $10K today (after 15% tax)
$261.54/yr
After 10yr DRIP, annual income (after tax)
$318.87/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,009.54/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VCON + MRK for your $10,000?

VCON: 50%MRK: 50%
100% MRK50/50100% VCON
Portfolio after 10yr
$40.6K
Annual income
$5,086.64/yr
Blended yield
12.54%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

VCON
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VCON buys
0
MRK buys
0
No recent congressional trades found for VCON or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVCONMRK
Forward yield3.08%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$24.4K$56.8K
Annual income after 10y$375.14$9,798.13
Total dividends collected$3.4K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VCON vs MRK ($10,000, DRIP)

YearVCON PortfolioVCON Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,008$307.69$11,206$366.19$198.00MRK
2$12,095$316.54$12,650$502.35$555.00MRK
3$13,266$325.05$14,407$694.19$1.1KMRK
4$14,528$333.21$16,585$967.82$2.1KMRK
5$15,886$341.03$19,342$1,363.89$3.5KMRK
6$17,347$348.51$22,913$1,947.19$5.6KMRK
7$18,917$355.66$27,662$2,823.89$8.7KMRK
8$20,603$362.48$34,159$4,173.35$13.6KMRK
9$22,415$368.97$43,337$6,308.80$20.9KMRK
10$24,359$375.14$56,776$9,798.13$32.4KMRK

VCON vs MRK: Complete Analysis 2026

VCONStock

Vicon Industries, Inc. designs, develops, assembles, and markets video management systems and system components for use in security, surveillance, safety, and communication applications worldwide. Its product line comprises various video and access control system elements, including cameras for image capture and stand-alone network video management system software, as well as various video recording, storage, management, output devices, and door controllers and peripherals; analog, digital, and high definition megapixel cameras for fixed and robotic positioning applications; and other video system components, such as video encoders decoders and monitors, camera lenses, housings and mounts, matrix video switchers and controls, and various video transmission devices. The company's access control system comprises electronic door controllers and communication panels, which is managed by network access control software. Its products are used by commercial and industrial users comprising office buildings, manufacturing plants, warehouses, apartment complexes, shopping malls, and retail stores; federal, state, and local governments for national security purposes, agency facilities, prisons, and military installations; and financial institutions that include banks, clearing houses, brokerage firms, and depositories for security purposes. The company's products are also used by transportation departments for highway traffic control, and bridge and tunnel monitoring, as well as airport, subway, bus, and seaport security and surveillance; gaming casinos; health care facilities, which comprise hospitals; and institutions of education, such as schools and universities, as well as hotels and sports arenas. It sells its products primarily to independent dealers, system integrators, and security products distributors. The company was founded in 1967 and is headquartered in Hauppauge, New York.

Full VCON Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this VCON vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VCON vs SCHDVCON vs JEPIVCON vs OVCON vs KOVCON vs MAINVCON vs JNJVCON vs ABBVVCON vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.